Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The weight loss medication tirzepatide (Mounjaro and Zepbound) is no longer in shortage, according to the FDA. Access to cheaper versions could end.
Weight Loss Drugs Changed Their Lives. Then They Lost Coverage.
In Michigan, the state’s largest insurer has tightened restrictions around medications like Wegovy. Patients are panicking.
FDA Approves Weight Loss Medication Zepbound to Treat Sleep Apnea
The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as tirzepatide, to help people treat their obstructive sleep apnea.
Yale doctor: Weight loss drugs could also help alcohol cravings
Weight loss drugs like Ozempic and Wegovy have seemingly taken over this year, curbing users appetites by making them feel full quicker. Could it also have the same effect on alcohol? Dr. Stephen Holt,
Weight loss drugs help with fat loss – but they cause bone and muscle loss too
Explore the world of weight loss drugs. Find out how GLP-1-based drugs can lead to significant weight loss, but also bone and muscle loss.
This Popular Weight Loss Drug Can Now Be Used To Treat Sleep Apnea
Zepbound is the first medication approved to treat people with obstructive sleep apnea, said Sailly Seymor, director of FDA's division of pulmonology, allergy, and critical care.
1d
IBX will no longer cover drugs like Ozempic when they are prescribed solely for weight loss
GLP-1 receptor agonists, which can cost around $1,300 a month, have caused an increase in premiums that “affect all members, ...
Hosted on MSN
5d
What to Know About Ozempic, Wegovy and the New Weight-Loss Market
Ozempic is a drug for diabetes, but it's also being used off-label for weight loss. Its active ingredient has inspired a new ...
1d
CT Medicaid accused of violating law by not covering weight loss drugs
One lawmaker said the CT Department of Social Services told him the agency wasn’t paying for FDA-approved drugs because of ...
dailymemphian
2d
‘It’s bonkers’ — how Ozempic, Wegovy change lives of those who struggle to lose weight
Unless the government intervenes to lower the price or forces insurers to cover the drugs, they will remain out of range for ...
2d
Independence Blue Cross to stop covering Wegovy, Ozempic as weight loss drugs in 2025
Independence Blue Cross said starting Jan. 1 it will only be covering GLP-1 agonists — commonly sold under brand names like ...
58m
on MSN
Lean-looking Elon Musk reveals he’s taking Mounjaro for weight loss in festive ‘Ozempic Santa’ post
Mounjaro, like Ozempic, is a GLP-1 inhibitor – a class of drugs developed to help people with diabetes regulate their blood ...
4d
Half a million people buying weight-loss jabs online because of ‘slow’ NHS rollout
More than half a million people are buying weight-loss injections online because of the “slow” rollout of the drugs by the ...
4d
on MSN
Novo Nordisk stock price takes a tumble after the Wegovy maker’s next-generation weight-loss drug underwhelms
Results for its new CagriSema drug, while promising, fell below expectations, sending shares of the pharmaceutical giant down ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback